Who we are We’re a global, midsize CRO that pushes boundaries, innovates and invents because the path to a cure for the world’s most persistent diseases is not paved by those who play it safe. It
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors
Company Description PSI is a leading full-service global Contract Research Organization providing a wide range of clinical trial services to the pharmaceutical and biotechnology industry, mainly for the development of clinical drugs. PSI has 3,000+ employees and 40+ affiliates
Role Summary The Hepatology Medical Science Liaison (MSL) is a field-based, non-promotional role supporting GSK’s clinical development activities in hepatology in Japan. This position is focused on supporting ongoing and planned clinical trials through high-quality scientific exchange with
Role Summary The Hepatology Medical Science Liaison (MSL) is a field-based, non-promotional role supporting GSK’s clinical development activities in hepatology in Japan. This position is focused on supporting ongoing and planned clinical trials through high-quality scientific exchange with